The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X GENOMICS INC | CL A COM | 88025U109 | 866,250 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | |||
2SEVENTY BIO INC | COM | 901384107 | 234,545 | 59,833 | SH | SOLE | 59,833 | 0 | 0 | |||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,009,936 | 240,400 | SH | SOLE | 240,400 | 0 | 0 | |||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 1,295,123 | 225,239 | SH | SOLE | 225,239 | 0 | 0 | |||
ALKERMES PLC | SHS | G01767105 | 1,400,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 340,480 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 684,720 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 294,600 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
ALPHATEC HOLDINGS INC | COM | 02081G201 | 1,037,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
ELUTIA INC | COM | 05479K106 | 2,366,913 | 1,655,184 | SH | SOLE | 1,655,184 | 0 | 0 | |||
AXOGEN INC | COM | 05463X106 | 865,000 | 173,000 | SH | SOLE | 173,000 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 141,600 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
BIODESIX INC | COM | 09075X108 | 8,315,394 | 5,039,633 | SH | SOLE | 5,039,633 | 0 | 0 | |||
BIODESIX INC COM RST | COM | 09075X108 | 211,765 | 153,703 | SH | SOLE | 153,703 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 1,383,808 | 455,200 | SH | SOLE | 455,200 | 0 | 0 | |||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 41,573,898 | 716,297 | SH | SOLE | 716,297 | 0 | 0 | |||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,362,250 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
CULLINAN ONCOLOGY INC | COM | 230031106 | 227,282 | 25,114 | SH | SOLE | 25,114 | 0 | 0 | |||
CYTOKINETICS INC | COM | 23282W605 | 736,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
DOCGO INC | COM | 256086109 | 692,900 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
EQUITRANS MIDSTREAM CORPORATIO | COM | 294600101 | 1,246,679 | 133,050 | SH | SOLE | 133,050 | 0 | 0 | |||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 1,324,215 | 264,843 | SH | SOLE | 264,843 | 0 | 0 | |||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 172,800 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 174,128 | 209,088 | SH | SOLE | 209,088 | 0 | 0 | |||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 382,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
HARROW HEALTH INC | COM | 415858109 | 2,155,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
IMMUNOGEN INC | COM | 45253H101 | 3,015,300 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | |||
INFLARX NV | COM | N44821101 | 149,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
INHIBRX INC | COM | 45720L107 | 1,292,721 | 70,448 | SH | SOLE | 70,448 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 385,200 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 766,255 | 571,832 | SH | SOLE | 571,832 | 0 | 0 | |||
KEROS THERAPEUTICS INC | COM | 492327101 | 223,160 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | |||
KINIKSA PHARMACEUTICALS LTD | COM | G5269C101 | 521,100 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
MASIMO CORP | COM | 574795100 | 1,339,750 | 15,280 | SH | SOLE | 15,280 | 0 | 0 | |||
NEKTAR THERAPEUTICS | COM | 640268108 | 16,677 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | |||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 8,689,500 | 77,240 | SH | SOLE | 77,240 | 0 | 0 | |||
OVINTIV INC | COM | 69047Q102 | 4,005,394 | 84,200 | SH | SOLE | 84,200 | 0 | 0 | |||
PHREESIA INC | COM | 71944F106 | 1,544,836 | 82,700 | SH | SOLE | 82,700 | 0 | 0 | |||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 872,290 | 3,800 | SH | SOLE | 3,800 | 0 | 0 | |||
PROGYNY INC | COM | 74340E103 | 612,360 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 633,840 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 8,181,946 | 169,574 | SH | SOLE | 169,574 | 0 | 0 | |||
QUIDELORTHO CORP | COM | 74838J101 | 4,762,427 | 65,203 | SH | SOLE | 65,203 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 303,050 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | |||
SILK ROAD MEDICAL INC | COM | 82710M100 | 618,997 | 41,294 | SH | SOLE | 41,294 | 0 | 0 | |||
STOKE THERAPEUTICS INC | COM | 86150R107 | 334,900 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 733,080 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 2,484,570 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 916,872 | 26,400 | SH | SOLE | 26,400 | 0 | 0 | |||
XENCOR INC | COM | 98401F105 | 247,845 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 341,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
YIELD10 BIOSCIENCE INC | COM | 98585K102 | 6,126 | 18,750 | SH | SOLE | 18,750 | 0 | 0 |